1. Home
  2. TMDX vs WSC Comparison

TMDX vs WSC Comparison

Compare TMDX & WSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • WSC
  • Stock Information
  • Founded
  • TMDX 1998
  • WSC 1944
  • Country
  • TMDX United States
  • WSC United States
  • Employees
  • TMDX N/A
  • WSC N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • WSC Misc Corporate Leasing Services
  • Sector
  • TMDX Health Care
  • WSC Industrials
  • Exchange
  • TMDX Nasdaq
  • WSC Nasdaq
  • Market Cap
  • TMDX 3.9B
  • WSC 3.8B
  • IPO Year
  • TMDX 2019
  • WSC N/A
  • Fundamental
  • Price
  • TMDX $115.69
  • WSC $21.69
  • Analyst Decision
  • TMDX Buy
  • WSC Buy
  • Analyst Count
  • TMDX 11
  • WSC 8
  • Target Price
  • TMDX $125.40
  • WSC $31.71
  • AVG Volume (30 Days)
  • TMDX 958.8K
  • WSC 2.2M
  • Earning Date
  • TMDX 10-27-2025
  • WSC 10-29-2025
  • Dividend Yield
  • TMDX N/A
  • WSC 1.29%
  • EPS Growth
  • TMDX 2163.11
  • WSC N/A
  • EPS
  • TMDX 2.02
  • WSC 0.59
  • Revenue
  • TMDX $531,292,000.00
  • WSC $2,352,581,000.00
  • Revenue This Year
  • TMDX $38.87
  • WSC N/A
  • Revenue Next Year
  • TMDX $20.70
  • WSC $3.15
  • P/E Ratio
  • TMDX $57.33
  • WSC $36.98
  • Revenue Growth
  • TMDX 48.09
  • WSC N/A
  • 52 Week Low
  • TMDX $55.00
  • WSC $20.08
  • 52 Week High
  • TMDX $146.98
  • WSC $42.15
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 49.53
  • WSC 40.16
  • Support Level
  • TMDX $109.77
  • WSC $20.08
  • Resistance Level
  • TMDX $115.90
  • WSC $23.66
  • Average True Range (ATR)
  • TMDX 4.84
  • WSC 0.62
  • MACD
  • TMDX -0.12
  • WSC 0.07
  • Stochastic Oscillator
  • TMDX 31.21
  • WSC 44.97

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About WSC WillScot Mobile Mini Holdings Corp.

WillScot Holdings Corp designs, delivers, and services onsite, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company includes modular office complexes, mobile offices, portable storage containers, and others.

Share on Social Networks: